There were 258 press releases posted in the last 24 hours and 426,050 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Cellceutix to Request Meeting With FDA for Phase 2 Ovarian Cancer Study; Company's First-in-Human Study Defines the Pharmacokinetic Profile of Kevetrin

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image